Literature DB >> 14515141

Plasma membrane rafts and chaperones in cytokine/STAT signaling.

Pravin B Sehgal1.   

Abstract

We and others have recently obtained data suggesting that cytokine-STAT signaling in many different cell-types is a chaperoned pathway initiated at the level of specialized plasma membrane microdomains called "rafts" (the "raft-STAT signaling hypothesis"). These findings are of broad significance in that all cytokines and growth factors initiate signaling in target cells by interacting with respective cell-surface receptors. The new data suggest that raft microdomains represent the units of function at the cell-surface through which ligand-stimulated STAT signaling is initiated. Moreover, recent evidence shows the involvement of chaperone proteins in regulating the STAT signaling pathway. These chaperones include the human homolog of the tumorous imaginal disc 1 protein (hTid1) which associates with Janus kinase 2 (JAK2) at the level of the plasma membrane, heat shock protein 90 (HSP90) which associates with STAT3 and STAT1 proteins in caveolin-1-containing raft and cytoplasmic complexes, and glucose regulated protein 58 (GRP58/ER-60/ERp57), a thiol dependent protein-disulfide isomerase, found in association with STAT3 "statosome" complexes in the cytosol and in the raft fraction. We suggest a function of the HSP90 chaperone system in preserving IL-6/STAT3 signaling in liver cells in the context of fever. The identification and function of protein partners associated with specific STAT species in rafts and in cytosolic complexes, and in the efficient departure of cytokine-activated STATs from the cytosolic face of rafts towards the cell nucleus are now areas of active investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515141     DOI: 035003583

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  14 in total

1.  Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection.

Authors:  Martynas Gavutis; Suman Lata; Peter Lamken; Pia Müller; Jacob Piehler
Journal:  Biophys J       Date:  2005-03-18       Impact factor: 4.033

Review 2.  Analytic review: Interleukin-6 in surgery, trauma, and critical care: part I: basic science.

Authors:  Randeep S Jawa; Sergio Anillo; Kristin Huntoon; Heinz Baumann; Mahmoud Kulaylat
Journal:  J Intensive Care Med       Date:  2011 Jan-Feb       Impact factor: 3.510

3.  Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.

Authors:  Elena Netchiporouk; Ivan V Litvinov; Linda Moreau; Martin Gilbert; Denis Sasseville; Madeleine Duvic
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Role of STAT3 and GATA-1 interactions in gamma-globin gene expression.

Authors:  Xiao Yao; Sirisha Kodeboyina; Li Liu; James Dzandu; Jose Sangerman; Solomon F Ofori-Acquah; Betty S Pace
Journal:  Exp Hematol       Date:  2009-05-15       Impact factor: 3.084

5.  JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth.

Authors:  Lori N Griner; Kathy L McGraw; Joseph O Johnson; Alan F List; Gary W Reuther
Journal:  Br J Haematol       Date:  2012-11-15       Impact factor: 6.998

Review 6.  Paradigm shifts in the cell biology of STAT signaling.

Authors:  Pravin B Sehgal
Journal:  Semin Cell Dev Biol       Date:  2008-07-24       Impact factor: 7.727

Review 7.  Contribution of chaperones to STAT pathway signaling.

Authors:  Claire E Bocchini; Moses M Kasembeli; Soung-Hun Roh; David J Tweardy
Journal:  JAKSTAT       Date:  2014-10-30

8.  Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?

Authors:  Y Ilan
Journal:  Clin Exp Immunol       Date:  2009-09-30       Impact factor: 4.330

9.  Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2.

Authors:  Gadi Lalazar; Ami Ben Ya'acov; Dan M Livovsky; Madi El Haj; Orit Pappo; Sarah Preston; Lidya Zolotarov; Yaron Ilan
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

10.  Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.

Authors:  Hosea F Huang; Thomas F Murphy; Ping Shu; Arnold B Barton; Beverly E Barton
Journal:  Mol Cancer       Date:  2005-01-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.